Compare IDYA & QUBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | QUBT |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2019 | 2019 |
| Metric | IDYA | QUBT |
|---|---|---|
| Price | $34.91 | $10.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $52.86 | $17.50 |
| AVG Volume (30 Days) | 1.2M | ★ 18.7M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.90 | ★ 84.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | $682,000.00 |
| Revenue This Year | N/A | $3,210.56 |
| Revenue Next Year | $201.05 | $51.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3024.43 | 82.84 |
| 52 Week Low | $20.50 | $6.18 |
| 52 Week High | $39.28 | $25.84 |
| Indicator | IDYA | QUBT |
|---|---|---|
| Relative Strength Index (RSI) | 69.60 | 50.27 |
| Support Level | $32.85 | $9.60 |
| Resistance Level | $36.01 | $13.19 |
| Average True Range (ATR) | 1.80 | 0.93 |
| MACD | 0.67 | -0.08 |
| Stochastic Oscillator | 92.17 | 42.77 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.